革兰阴性菌血流感染：抗菌药物耐药性对临床结局和治疗的影响
Gram-Negative Bloodstream Infection: Implications of Antimicrobial Resistance on Clinical Outcomes and Therapy.
作者信息
Al-Hasan Majdi N
机构信息
Department of Medicine, Division of Infectious Diseases, University of South Carolina School of Medicine, Columbia, SC 29209, USA.
Department of Medicine, Division of Infectious Diseases, Prisma Health-Midlands, Columbia, SC 29203, USA.
出版信息
Antibiotics (Basel). 2020 Dec 18;9(12):922. doi: 10.3390/antibiotics9120922.
Abstract
The age- and sex-adjusted incidence rate of Gram-negative bloodstream infection (GN-BSI) is 84 [...].
摘要
革兰氏阴性菌血流感染（GN-BSI）的年龄和性别调整发病率为84 [...].
相似文献
1
Gram-Negative Bloodstream Infection: Implications of Antimicrobial Resistance on Clinical Outcomes and Therapy.革兰阴性菌血流感染：抗菌药物耐药性对临床结局和治疗的影响
Antibiotics (Basel). 2020 Dec 18;9(12):922. doi: 10.3390/antibiotics9120922.
2
Evaluation of early clinical failure criteria for gram-negative bloodstream infections.革兰氏阴性菌血流感染早期临床失败标准的评估。
Clin Microbiol Infect. 2020 Jan;26(1):73-77. doi: 10.1016/j.cmi.2019.05.017. Epub 2019 May 31.
3
Impact of fluoroquinolone resistance in Gram-negative bloodstream infections on healthcare utilization.氟喹诺酮类耐药性对革兰氏阴性菌血流感染患者医疗资源利用的影响。
Clin Microbiol Infect. 2015 Sep;21(9):843-9. doi: 10.1016/j.cmi.2015.05.013. Epub 2015 May 21.
4
Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis.革兰阴性菌血流感染中不恰当经验性抗菌治疗与住院时间的关联：按预后分层
J Antimicrob Chemother. 2017 Jan;72(1):299-304. doi: 10.1093/jac/dkw402. Epub 2016 Sep 28.
5
Clinical and microbiological features of resistant gram-negative bloodstream infections in children.儿童耐革兰氏阴性菌血流感染的临床和微生物学特征
J Infect Public Health. 2017 Mar-Apr;10(2):211-218. doi: 10.1016/j.jiph.2016.04.011. Epub 2016 May 12.
6
The Use of Bloodstream Infection Mortality to Measure the Impact of Antimicrobial Stewardship Interventions: Assessing the Evidence.利用血流感染死亡率评估抗菌药物管理干预措施的影响：评估证据
Infect Dis Rep. 2017 Mar 30;9(1):6849. doi: 10.4081/idr.2017.6849.
7
Rapid testing using the Verigene Gram-negative blood culture nucleic acid test in combination with antimicrobial stewardship intervention against Gram-negative bacteremia.使用Verigene革兰氏阴性血培养核酸检测进行快速检测并联合抗菌药物管理干预以应对革兰氏阴性菌血症。
Antimicrob Agents Chemother. 2015 Mar;59(3):1588-95. doi: 10.1128/AAC.04259-14. Epub 2014 Dec 29.
8
Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients.中性粒细胞减少症癌症患者血流感染的病因、临床特征、抗菌药物耐药性和转归的变化。
Clin Microbiol Infect. 2013 May;19(5):474-9. doi: 10.1111/j.1469-0691.2012.03879.x. Epub 2012 Apr 24.
9
The Hypothetical Impact of Accelerate Pheno on Time to Effective Therapy and Time to Definitive Therapy for Bloodstream Infections Due to Drug-Resistant Gram-Negative Bacilli.耐药革兰氏阴性杆菌血流感染的有效治疗时间和确定性治疗时间因 Accelerate Pheno 而产生的假设性影响。
Antimicrob Agents Chemother. 2019 Feb 26;63(3). doi: 10.1128/AAC.01477-18. Print 2019 Mar.
10
Seasonal variation in health care-associated bloodstream infection: increase in the incidence of gram-negative bacteremia in nonhospitalized patients during summer.季节性变化与医疗保健相关的血流感染：夏季非住院患者革兰氏阴性菌血症的发病率增加。
Am J Infect Control. 2013 Dec;41(12):1205-8. doi: 10.1016/j.ajic.2013.05.019. Epub 2013 Aug 21.
引用本文的文献
1
The epidemiology of gram-negative bacteremia in Lebanon: a study in four hospitals.黎巴嫩革兰氏阴性菌菌血症的流行病学：四家医院的研究。
Ann Clin Microbiol Antimicrob. 2024 Oct 9;23(1):90. doi: 10.1186/s12941-024-00740-0.
2
Adult acute leukemia patients with gram-negative bacteria bloodstream infection: Risk factors and outcomes of antibiotic-resistant bacteria.成人急性白血病合并革兰阴性菌血流感染：耐药菌的危险因素和结局。
Ann Hematol. 2024 Oct;103(10):4021-4031. doi: 10.1007/s00277-024-05866-x. Epub 2024 Jul 3.
3
Antibiotic Therapy Strategies for Treating Gram-Negative Severe Infections in the Critically Ill: A Narrative Review.治疗危重症患者革兰阴性菌严重感染的抗生素治疗策略：一篇叙述性综述
Antibiotics (Basel). 2023 Jul 31;12(8):1262. doi: 10.3390/antibiotics12081262.
4
Bacteriological Profile and Antimicrobial Susceptibility Patterns of Gram-Negative Bloodstream Infection and Risk Factors Associated with Mortality and Drug Resistance: A Retrospective Study from Shanxi, China.革兰阴性菌血流感染的细菌学特征、抗菌药物敏感性模式及与死亡率和耐药性相关的危险因素：来自中国山西的一项回顾性研究
Infect Drug Resist. 2022 Jul 6;15:3561-3578. doi: 10.2147/IDR.S370326. eCollection 2022.
本文引用的文献
1
Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance.耐多药革兰阴性菌所致血流感染的治疗
Antibiotics (Basel). 2020 Sep 22;9(9):632. doi: 10.3390/antibiotics9090632.
2
Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals.基于体外药敏结果不一致的血流感染经验性抗生素治疗不当：美国医院的患病率、预测因素和死亡风险的回顾性队列分析。
Lancet Infect Dis. 2021 Feb;21(2):241-251. doi: 10.1016/S1473-3099(20)30477-1. Epub 2020 Sep 8.
3
Current Concepts in Community and Ventilator Associated Lower Respiratory Tract Infections in ICU Patients.重症监护病房患者社区获得性和呼吸机相关性下呼吸道感染的当前概念
Antibiotics (Basel). 2020 Jul 5;9(7):380. doi: 10.3390/antibiotics9070380.
4
Iron Chelation in Murine Models of Systemic Inflammation Induced by Gram-Positive and Gram-Negative Toxins.革兰氏阳性和革兰氏阴性毒素诱导的全身炎症小鼠模型中的铁螯合作用
Antibiotics (Basel). 2020 May 26;9(6):283. doi: 10.3390/antibiotics9060283.
5
Molecular Typing, Characterization of Antimicrobial Resistance, Virulence Profiling and Analysis of Whole-Genome Sequence of Clinical Isolates.临床分离株的分子分型、抗菌药物耐药性特征分析、毒力谱分析及全基因组序列分析
Antibiotics (Basel). 2020 May 17;9(5):261. doi: 10.3390/antibiotics9050261.
6
Multicenter, Observational Cohort Study Evaluating Third-Generation Cephalosporin Therapy for Bloodstream Infections Secondary to , , and Species.评估第三代头孢菌素治疗由、和菌种引起的血流感染的多中心观察性队列研究。
Antibiotics (Basel). 2020 May 14;9(5):254. doi: 10.3390/antibiotics9050254.
7
Impact of Reappraisal of Fluoroquinolone Minimum Inhibitory Concentration Susceptibility Breakpoints in Gram-Negative Bloodstream Isolates.氟喹诺酮类药物对革兰氏阴性血流分离株最低抑菌浓度药敏断点重新评估的影响
Antibiotics (Basel). 2020 Apr 17;9(4):189. doi: 10.3390/antibiotics9040189.
8
Gram-negative Bacteria With Difficult-to-Treat Resistance: A Moving Target.具有难以治疗的耐药性的革兰氏阴性菌：一个不断变化的目标。
Clin Infect Dis. 2021 Jun 15;72(12):2121-2123. doi: 10.1093/cid/ciaa384.
9
Excess Length of Acute Inpatient Stay Attributable to Acquisition of Hospital-Onset Gram-Negative Bloodstream Infection with and without Antibiotic Resistance: A Multistate Model Analysis.因获得有或无抗生素耐药性的医院获得性革兰氏阴性血流感染导致的急性住院时间延长：多州模型分析
Antibiotics (Basel). 2020 Feb 23;9(2):96. doi: 10.3390/antibiotics9020096.
10
Definitive Cefazolin Treatment for Community-Onset Enterobacteriaceae Bacteremia Based on the Contemporary CLSI Breakpoint: Clinical Experience of a Medical Center in Southern Taiwan.基于当代CLSI标准的社区获得性肠杆菌科菌血症的确切头孢唑林治疗：台湾南部某医疗中心的临床经验
Antibiotics (Basel). 2019 Nov 10;8(4):216. doi: 10.3390/antibiotics8040216.
Zotero 插件